191 related articles for article (PubMed ID: 30987187)
41. The uncharged surface features surrounding the active site of Escherichia coli DsbA are conserved and are implicated in peptide binding.
Guddat LW; Bardwell JC; Zander T; Martin JL
Protein Sci; 1997 Jun; 6(6):1148-56. PubMed ID: 9194175
[TBL] [Abstract][Full Text] [Related]
42. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.
Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J
J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340
[TBL] [Abstract][Full Text] [Related]
43. Effect of site-directed mutations in multidrug efflux pump AcrB examined by quantitative efflux assays.
Kinana AD; Vargiu AV; Nikaido H
Biochem Biophys Res Commun; 2016 Nov; 480(4):552-557. PubMed ID: 27789287
[TBL] [Abstract][Full Text] [Related]
44. Structural and energetic insight into the interactions between the benzolactam inhibitors and tumor marker HSP90α.
Guo XY; Qi RP; Xu DG; Liu XH; Yang X
Comput Biol Chem; 2015 Oct; 58():182-91. PubMed ID: 26256798
[TBL] [Abstract][Full Text] [Related]
45. Peptide inhibitors of the Escherichia coli DsbA oxidative machinery essential for bacterial virulence.
Duprez W; Premkumar L; Halili MA; Lindahl F; Reid RC; Fairlie DP; Martin JL
J Med Chem; 2015 Jan; 58(2):577-87. PubMed ID: 25470204
[TBL] [Abstract][Full Text] [Related]
46. Fluorescence quenching in the DsbA protein from Escherichia coli: complete picture of the excited-state energy pathway and evidence for the reshuffling dynamics of the microstates of tryptophan.
Sillen A; Hennecke J; Roethlisberger D; Glockshuber R; Engelborghs Y
Proteins; 1999 Nov; 37(2):253-63. PubMed ID: 10584070
[TBL] [Abstract][Full Text] [Related]
47. Snapshots of DsbA in action: detection of proteins in the process of oxidative folding.
Kadokura H; Tian H; Zander T; Bardwell JC; Beckwith J
Science; 2004 Jan; 303(5657):534-7. PubMed ID: 14739460
[TBL] [Abstract][Full Text] [Related]
48. Conformations of the signal recognition particle protein Ffh from Escherichia coli as determined by FRET.
Buskiewicz I; Peske F; Wieden HJ; Gryczynski I; Rodnina MV; Wintermeyer W
J Mol Biol; 2005 Aug; 351(2):417-30. PubMed ID: 16005894
[TBL] [Abstract][Full Text] [Related]
49. A selection for mutants that interfere with folding of Escherichia coli thioredoxin-1 in vivo.
Huber D; Cha MI; Debarbieux L; Planson AG; Cruz N; López G; Tasayco ML; Chaffotte A; Beckwith J
Proc Natl Acad Sci U S A; 2005 Dec; 102(52):18872-7. PubMed ID: 16357193
[TBL] [Abstract][Full Text] [Related]
50. Affinity and path of binding xylopyranose unto E. coli xylose permease.
Wambo TO; Chen LY; Phelix C; Perry G
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):202-206. PubMed ID: 29032199
[TBL] [Abstract][Full Text] [Related]
51. Identification of the Thioredoxin Partner of Vitamin K Epoxide Reductase in Mycobacterial Disulfide Bond Formation.
Ke N; Landeta C; Wang X; Boyd D; Eser M; Beckwith J
J Bacteriol; 2018 Aug; 200(16):. PubMed ID: 29784887
[TBL] [Abstract][Full Text] [Related]
52. A system for concomitant overexpression of four periplasmic folding catalysts to improve secretory protein production in Escherichia coli.
Schlapschy M; Grimm S; Skerra A
Protein Eng Des Sel; 2006 Aug; 19(8):385-90. PubMed ID: 16720693
[TBL] [Abstract][Full Text] [Related]
53. Structure, dynamics and electrostatics of the active site of glutaredoxin 3 from Escherichia coli: comparison with functionally related proteins.
Foloppe N; Sagemark J; Nordstrand K; Berndt KD; Nilsson L
J Mol Biol; 2001 Jul; 310(2):449-70. PubMed ID: 11428900
[TBL] [Abstract][Full Text] [Related]
54. Replacement of the active-site cysteine residues of DsbA, a protein required for disulfide bond formation in vivo.
Zapun A; Cooper L; Creighton TE
Biochemistry; 1994 Feb; 33(7):1907-14. PubMed ID: 8110795
[TBL] [Abstract][Full Text] [Related]
55. Effect of sequences of the active-site dipeptides of DsbA and DsbC on in vivo folding of multidisulfide proteins in Escherichia coli.
Bessette PH; Qiu J; Bardwell JC; Swartz JR; Georgiou G
J Bacteriol; 2001 Feb; 183(3):980-8. PubMed ID: 11208797
[TBL] [Abstract][Full Text] [Related]
56. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
Chaudhari HK; Pahelkar A
Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898
[TBL] [Abstract][Full Text] [Related]
57. Mutations of the membrane-bound disulfide reductase DsbD that block electron transfer steps from cytoplasm to periplasm in Escherichia coli.
Cho SH; Beckwith J
J Bacteriol; 2006 Jul; 188(14):5066-76. PubMed ID: 16816179
[TBL] [Abstract][Full Text] [Related]
58. Limited tolerance towards folded elements during secretion of the autotransporter Hbp.
Jong WS; ten Hagen-Jongman CM; den Blaauwen T; Slotboom DJ; Tame JR; Wickström D; de Gier JW; Otto BR; Luirink J
Mol Microbiol; 2007 Mar; 63(5):1524-36. PubMed ID: 17302825
[TBL] [Abstract][Full Text] [Related]
59. Structural insights into the binding mode of flavonols with the active site of matrix metalloproteinase-9 through molecular docking and molecular dynamic simulations studies.
Pradiba D; Aarthy M; Shunmugapriya V; Singh SK; Vasanthi M
J Biomol Struct Dyn; 2018 Nov; 36(14):3718-3739. PubMed ID: 29068268
[TBL] [Abstract][Full Text] [Related]
60. An integrated computational approach of molecular dynamics simulations, receptor binding studies and pharmacophore mapping analysis in search of potent inhibitors against tuberculosis.
Agarwal S; Verma E; Kumar V; Lall N; Sau S; Iyer AK; Kashaw SK
J Mol Graph Model; 2018 Aug; 83():17-32. PubMed ID: 29753941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
